Recent Articles
Custom Modified Antibodies: Deco...
Pan-Lactylation Antibodies Uncov...
How One-Stop Antibody Customizat...
Succinylation Antibodies: Unveiling the Pivotal Role of Protein Modification ...
1. Literature Information Research Topic: The regulatory role of protein succinylation in tumorigenesis, metabolic disorders, and degenerative diseases Core Findings: Succinylation dysregulation drives disease progression by modulating metabolic enzyme activity,...
Succinylation Antibodies: Unveiling the Pivotal Role of Protein Modification ...
1. Literature Information Research Topic: The regulatory role of protein succinylation in tumorigenesis, metabolic disorders, and degenerative diseases Core Findings: Succinylation dysregulation drives disease progression by modulating metabolic enzyme activity,...
Read More
BAFF/TNFSF13B: The Central Regulator in B Cell Immunity and Autoimmunity—A Kn...
1. Concept B-cell activating factor (BAFF), also known as B lymphocyte stimulator (BLyS) or TNFSF13B, is a key member of the tumor necrosis factor (TNF) superfamily. As a type II...
BAFF/TNFSF13B: The Central Regulator in B Cell Immunity and Autoimmunity—A Kn...
1. Concept B-cell activating factor (BAFF), also known as B lymphocyte stimulator (BLyS) or TNFSF13B, is a key member of the tumor necrosis factor (TNF) superfamily. As a type II...
Read More
Lactylation Antibodies Uncover Novel Mechanisms of Tumor Ferroptosis Resistan...
1. Literature Information Research Topic: Lactylation-mediated SUMO2 modification drives ferroptosis resistance in lung adenocarcinoma Core Finding: SUMO2-K11 lactylation regulates ACSL4 stability to inhibit ferroptosis, promoting tumor progression and chemotherapy resistance...
Lactylation Antibodies Uncover Novel Mechanisms of Tumor Ferroptosis Resistan...
1. Literature Information Research Topic: Lactylation-mediated SUMO2 modification drives ferroptosis resistance in lung adenocarcinoma Core Finding: SUMO2-K11 lactylation regulates ACSL4 stability to inhibit ferroptosis, promoting tumor progression and chemotherapy resistance...
Read More
c-Myc Antibodies: Unveiling New Mechanisms of Protein Interaction in Gene Exp...
1. Literature Information Research Focus: Exploration of c-Myc’s interaction with HBXIP, validation of their direct binding, identification of key interaction domains, and the functional role of the protein complex in...
c-Myc Antibodies: Unveiling New Mechanisms of Protein Interaction in Gene Exp...
1. Literature Information Research Focus: Exploration of c-Myc’s interaction with HBXIP, validation of their direct binding, identification of key interaction domains, and the functional role of the protein complex in...
Read More
c-Met Antibodies: New Hope for Tumor Targeted Therapy
1. Literature Information Research Focus: Exploration of c-Met receptor’s role in tumorigenesis, unique advantages of c-Met antibody drugs, R&D challenges, breakthroughs from bispecific antibodies/ADCs, clinical application optimization, and future directions....
c-Met Antibodies: New Hope for Tumor Targeted Therapy
1. Literature Information Research Focus: Exploration of c-Met receptor’s role in tumorigenesis, unique advantages of c-Met antibody drugs, R&D challenges, breakthroughs from bispecific antibodies/ADCs, clinical application optimization, and future directions....
Read More
Claudin18.2 Antibodies: A New Breakthrough in Gastric Cancer Targeted Therapy
1. Literature Information Research Focus: Exploration of Claudin18.2’s unique expression profile, the mechanism of action of Claudin18.2 antibodies, international and domestic clinical research progress, current R&D challenges, and future development...
Claudin18.2 Antibodies: A New Breakthrough in Gastric Cancer Targeted Therapy
1. Literature Information Research Focus: Exploration of Claudin18.2’s unique expression profile, the mechanism of action of Claudin18.2 antibodies, international and domestic clinical research progress, current R&D challenges, and future development...
Read More